Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Efficacy and Safety of Zavegepant Nasal Spray for the Acute Treatment of Migraine: Results of a Phase 3 Double-Blind, Randomized, Placebo Controlled Trial

              Author:Mullin, Kathleen   Croop, Robert   Pavlovic, Jelena   Mosher, Linda   Smith, Timothy   Madonia, Jennifer   Lovegren, Meghan   Lipton, Richard   

              Session Name:PL5: Clinical Trials Plenary Session  

              Topic:Headache  

              Program Number:PL5.002  

              Author Institution:New England Institute for Neurology and Headache, Stamford, CT  Biohaven Pharmaceuticals, Wynnewood, PA  Albert Einstein College of Medicine, Bronx, NY  Biohaven Pharmaceuticals, Wallingford, CT  StudyMetrix Research, St Louis, MO  Biohaven Pharmaceuticals, New Haven, CT